E Risi

No pain, no gain… What we can learn from a trial reporting negative results.

L Biganzoli, A. Di Leo, L. Biganzoli, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

L Biganzoli, F Puglisi, M Buyse, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.